Guidance for 2025

Guidance for 2025 was updated on 17 July 2025.

Guidance for 2025

Terveystalo clarifies the structure of its guidance and now provides a range for adjusted EBIT in euros instead of revenue and adjusted EBIT margin.

Terveystalo expects its full-year 2025  adjusted EBIT to be EUR 155-165 million (2024: EUR 140.5 million).

The estimates are based on a stable demand environment, employment levels, and typical morbidity rates. The estimates account for a decrease of approximately EUR 30 million in revenue within the Portfolio Businesses segment's outsourcing operations due to the ending of contracts. Profitability is expected to strengthen in all business segments. The estimates do not account for significant acquisitions or divestments.

 

Guidance for 2025 on 25 April 2025

Terveystalo has updated the structure of the guidance and communicates expectations on revenue and adjusted EBIT margin (previously revenue and adjusted EBITA margin).
Terveystalo expects its full-year 2025 revenue to grow (2024: EUR 1,340 million) and adjusted EBIT to be 10.7–11.8 percent of revenue (2024: 10.5 percent).

The estimates are based on a stable demand environment, employment levels, and typical morbidity rates. The estimates account for a decrease of approximately EUR 25 million in revenue within the Portfolio Businesses segment's outsourcing operations due to the ending of contracts. Profitability is expected to strengthen in all business segments. The estimates do not account for significant acquisitions or divestments.